Rabies virus (RABV), scientific name Rabies lyssavirus, is a deadly neurotropic virus that causes rabies in humans and animals. Rabies virus has an extremely wide host range and its transmission most often occur through the saliva of animals. Without intervention prior to disease progression, rabies has the highest case fatality of any infectious disease. RABV contains a singlestranded negativesense RNA genome that encodes five structural proteins: nucleoprotein (N), phosphoprotein (P), matrix protein (M), glycoprotein (G), and RNAdependent RNA polymerase (L). Among these viral proteins, the RABV glycoprotein (RABVG) is a pivotal player mediating virus entry and the major target of neutralizing antibodies, thus a key factor for vaccine and drug design. - Antikörper
Tag:
Human IgG1 | Human Kappa
Puffer:
PBS, pH7.4
Reinheit:
0.9
Formulierung:
Powder
Target-Kategorie:
Glycoprotein/G Protein (RABV)
Immobilized Rabies virus Glycoprotein G, His Tag (Cat. No. RAG-V55H5) at 1 µg/mL (100 µL/well) can bind Monoclonal Anti-Glycoprotein G(Lyssavirus rabies) Antibody, Human IgG1 (4A7) (Cat. No. GLN-M645) with a linear range of 0.1-1 ng/mL (QC tested).
Monoclonal Anti-Glycoprotein G(Lyssavirus rabies) Antibody, Human IgG1 (4A7) on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 0.9.
GLN-M645-1mg
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
